e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 70

Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches

Karol Sadowski; Adrianna Jażdżewska; Jan Kozłowski; Aleksandra Zacny; Tomasz Lorenc; Wioletta Olejarz · 2024 · International Journal of Molecular Sciences

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Glioblastoma is the most common malignant primary brain tumor in the adult population, with an average survival of 12.1 to 14.6 months. The standard treatment, combining surgery, radiotherapy, and chemotherapy, is not as efficient as we would like. However, the current possibilities are no longer limited to the standard therapies due to rapid advancements in biotechnology. New methods enable a more precise approach by targeting individual cells and antigens to overcome cancer. For the treatment of glioblastoma, these are gamma knife therapy, proton beam therapy, tumor-treating fields, EGFR and

Abstract by Karol Sadowski; Adrianna Jażdżewska; Jan Kozłowski; Aleksandra Zacny; Tomasz Lorenc; Wioletta Olejarz, International Journal of Molecular Sciences (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3390/ijms25115774